US Stock MarketDetailed Quotes

IMVT Immunovant

Watchlist
  • 14.825
  • +0.375+2.60%
Trading Apr 24 14:56 ET
2.52BMarket Cap-5.66P/E (TTM)

Immunovant Key Stats

Immunovant Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 0.000--
--2025/Q4-- / 0.000--
--2025/Q30.000 / 0.000--
Nov 7, 20242025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 0.000--
--2025/Q4-- / 0.000--
--2025/Q30.000 / 0.000--
Nov 7, 20242025/Q20.000 / 0.000--
--2025/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Immunovant Earnings Reports

Read more

Market Insights

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More